| Trial ID: | L0026 |
| Source ID: | NCT01083992
|
| Associated Drug: |
Vitagliptin
|
| Title: |
Role of Vitagliptin and Vitamin D in the Treatment of Non Alcoholic Fatty Liver Disease (NAFLD)
|
| Acronym: |
--
|
| Status: |
Unknown status
|
| Study Results: |
No Results Available
|
| Results: |
--
|
| Conditions: |
Non-Alcoholic Fatty Liver Disease
|
| Interventions: |
Drug: Galvus (vitagliptin)|Drug: Galvus + vitamin D
|
| Outcome Measures: |
decrease in histological findings
|
| Sponsor/Collaborators: |
Ziv Hospital
|
| Gender: |
All
|
| Age: |
18 Years to 65 Years ?? (Adult, Older Adult)
|
| Phases: |
Not applicable
|
| Enrollment: |
60
|
| Study Type: |
Interventional
|
| Study Designs: |
Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment
|
| Start Date: |
April 2012
|
| Completion Date: |
June 2013
|
| Results First Posted: |
--
|
| Last Update Posted: |
April 28, 2011
|
| Locations: |
Ziv medical center liver unit, Safed, Israel, Israel
|
| URL: |
https://ClinicalTrials.gov/show/NCT01083992
|
